glp-1 and alcohol side effects Anti-Obesity Rx and Substance Use Disorders GI Adverse Effects of Glucagon-Like

Exenatide once weekly for alcohol use disorder: A randomized, placebo-controlled trial

" "For patients diagnosed with diabetes mellitus on a very low energy/liver reduction diet for the purposes of surgery, sodium-glucose cotransporter-2 inhibitors should be stopped at commencement of the diet, and adjust diabetes mellitus treatment as necessary." "Written sick-day rules should be provided to patients at pre-operative assessment and at discharge." 3.5 Comparison with Other Guidelines: 3.5.1 American Heart Association (AHA) Guidelines [4] : "In patients scheduled for NCS, SGLT2i should be discontinued 3 to 4 days* days before surgery to reduce the risk of perioperative metabolic acidosis (COR I/LOE C-LD) *Canagliflozin, dapagliflozin, and empagliflozin should be stopped 3 days and ertugliflozin 4 days before scheduled surgery." 3.5.2 European Society of Cardiology (ESC) Guidelines [5] : "It should be considered to interrupt SGLT-2 inhibitor therapy for at least 3 days before intermediate- and high-risk NCS." (Class IIa/Level C) 3.5.3 ESAIC Guidelines [3] : "R12.8: SGLT2 inhibitors (SGLT2i) drugs should be withheld for 3 to 4 days before elective procedures to reduce the risk of euglycemic diabetic ketoacidosis

Research shows that many patients regain weight after discontinuing GLP-1 therapy, which raises questions about whether insurance should cover indefinite use

Novo Nordisk explicitly blamed off-brand telehealth companies, such as Hims & Hers Health, for eating into its market share

Spreadsheet Flexible, but often too much work on mobile and easy to abandon

Typically, you can switch from one of these medications to the other with your healthcare teams approval and guidance